UnitedHealth Group Incorporated
Every calculator, already run for UNH
Open the full toolkit →You have the numbers on UNH. Get the argument.
A written report on which of these readings actually decide the outcome for UnitedHealth Group Incorporated, what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
27 analysts covering UNHAnalyst Price Target Disagreement for UnitedHealth Group Incorporated
Wall Street's bull case implies +32% from the current price; the bear case implies -22%. A 54% spread signals high analyst disagreement — run your own DCF to anchor on fundamentals rather than street consensus.
Ownership & short interest
About UnitedHealth Group Incorporated
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services with patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, public entities, life sciences companies and other organizations. T…
UNH — frequently asked
Is UNH a buy right now?
Wall Street's consensus rating on UnitedHealth Group Incorporated is Buy across 27 analysts, with a mean price target of $475.23 (+18% vs. the current $401.73). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is UNH overvalued?
UNH trades at 25.8x trailing earnings, against a DCF fair value of $836 per share. The current price implies -3% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is UNH's next earnings date?
UnitedHealth Group Incorporated is next scheduled to report earnings around Oct 27, 2026. A full UNH research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for UnitedHealth Group Incorporated?
Analysts covering UnitedHealth Group Incorporated (UNH) range from a bear-case target of $313.00 to a bull-case high of $529.00, with a mean consensus target of $475.23 across 26 analysts. The spread of $216.00 (54% of the current price) indicates high disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare UnitedHealth Group Incorporated against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For UnitedHealth Group Incorporated
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full UNH research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on UnitedHealth Group Incorporated, in minutes. 3 free reports included with every account — no credit card required.